| 英文名称 |
中文名称 |
CAS |
|
tert-Butyl ((2S,3S)-4-chloro-3-hydroxy-1-phenylbutan-2-yl)carbamate
|
((2S,3S)-4-氯-3-羟基-1-苯基丁-2-基)氨基甲酸叔丁酯 |
165727-45-7 |
|
tert-Butyl ((2S,3R)-4-chloro-3-hydroxy-1-phenylbutan-2-yl)carbamate
|
(2R,3S)-3-叔丁氧羰基-1-氯-2-羟基-4-苯基丁烷 |
162536-40-5 |
|
4-Aminophthalhydrazide
|
异鲁米诺 |
3682-14-2 |
|
Etoricoxib Solution, 100ppm;Etoricoxib (MK-663;Etoricoxib Tablets;Etoricoxib(5-chloro-6'-Methyl-3-(4-(Methylsulfonyl)phenyl)-2,3'-bipyridine;
|
依托考昔；2,3'-联吡啶, 5-氯-6'-甲基-3-[4-(甲基磺酰基)苯基]-;依托考西;依他昔布 |
202409-33-4 |
|
AZD2281(olaparib);4-(3-(1-(cyclopropanecarbonyl)piperazine-4-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one
|
奥拉帕尼；PARP 抑制剂;4-[4-氟-3-(哌嗪-1-环丙基羰基)苄 基]-2H-酞嗪-1-酮; |
763113-22-0 |
|
Nintedanib esylate
|
乙磺酸尼达尼布 |
656247-18-6 |
|
KX2-391
|
5-[4-[2-(4-吗啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺 |
897016-82-9 |
|
2,6-Dichlorophenolindophenol sodium salt xhydrate
|
2,6-二氯靛酚 钠盐 水合物 |
1266615-56-8 |
|
Brensocatib
|
|
1802148-05-5 |
|
Poly(ethyl vinyl ether)
|
聚乙烯基乙醚 |
25104-37-4 |
|
NHS
|
N-羟基丁二酰亚胺 |
6066-82-6 |
|
Hexaammineruthenium(III) chloride
|
三氯化六铵合钌 |
14282-91-8 |
|
AMPPD
|
3-(2'-螺旋金刚烷)-4-甲氧基-4-(3"-磷酰氧基)苯-1,2-二氧杂环丁烷 |
122341-56-4 |
|
Gepirone
|
吉哌隆 |
83928-76-1 |
|
Tetrabromophenol blue
|
四溴酚蓝 |
4430-25-5 |
|
Thionicotinamide adenine dinucleotide
|
硫代氧化型辅酶 I |
4090-29-3 |
|
Morpholine hydrochloride
|
吗啡啉盐酸盐 |
10024-89-2 |
|
2-Chloro-4-nitrophenyl-alpha-L-fucopyranoside
|
2-氯-4-硝基苯-α-L-岩藻糖苷 |
157843-41-9 |
|
TG101348; TG 101348; TG-101348; SAR302503; SAR-302503; SAR 302503; FEDRATINIB.;TG101348(Fedratinib);CS-57;TG-101348; TG 101348;
|
fedratinib；JAK2抑制剂(TG-101348);费曲替尼;菲卓替尼;化合物FEDRATINIB; |
936091-26-8 |
|
NSP-SA
|
吖啶酸丙磺酸盐 |
211106-69-3 |
|
ApreMilast,CC-10004;brand name: Otezla.;CC10004; CC-10004; CC 10004; APREMILAST; BRAND NAME: OTEZLA.;
|
阿普斯特；匹米斯特;(+)-2-[1-(3-乙氧基-4-甲氧基苯基)-2-甲基磺酰乙基]-4-乙酰氨基异吲哚啉-Chemicalbook1,3-二酮;阿普斯特(APREMILAST);阿普司特;APREMILASTCC-10004阿普斯特 |
608141-41-9 |
|
Selinexor
|
塞利尼索 |
1393477-72-9 |
|
aprocitentan
|
阿西替坦 |
1103522-45-7 |
|
DFSX-2;Ethyl1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate;
|
德拉沙星;1-(6-氨基-3,5-二氟吡啶-2-基)-6-氟-7-[3-(异丁酰氧基)氮杂环丁烷-1-基]-4-氧代-1,4-二氢喹啉-3-甲酸乙酯; |
442526-91-2 |
|
3-Aminophthalhydrazide
|
3-氨基邻苯二甲酰肼 |
521-31-3 |
|
Linezolid-13C-d3;Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]- (9CI);
|
利奈唑胺；雷奈佐利(利奈唑胺);利奈唑胺(游离);吗啉恶酮(标准品);雷奈佐利;利奈唑胺 |
165800-03-3 |
|
POLY(VINYL METHYL ETHER)
|
聚乙烯甲基醚、聚乙烯基甲醚 |
9003-09-3 |
|
4-(1H-imidazol-1-yl)phenol
|
4-（咪唑-1-基）苯酚 |
10041-02-8 |
|
Triisopropanolamine Borate
|
三异丙醇胺环硼酸盐 |
101-00-8 |
|
β-NADH
|
还原型烟酰胺腺嘌呤二核苷酸 |
606-68-8 |
|
aficamten
|
|
2364554-48-1 |
|
Undecylenoyl phenylalanine
|
十一碳烯酰基苯丙氨酸 |
175357-18-3 |
|
AZILSARTAN;2-Ethoxy-1-[[2'-(4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid Azilsartan;
|
阿齐沙坦；阿齐沙坦酯杂质A;阿齐沙坦(降压药);阿齐沙坦INT E;阿奇沙坦 10G;阿齐沙坦, ≥98% (HPLC);阿齐沙坦原料药;阿齐沙坦(阿齐主链) |
147403-03-0 |
|
Prucalopride
|
普卡必利 |
179474-81-8 |
|
N(4)-hydroxycytidine
|
N-羟基胞苷 |
3258-02-4 |
|
2,5,6-TRICHLORO-1H-BENZIMIDAZOLE
|
2,5,6-三氯苯并咪唑 |
16865-11-5 |
|
Mirabegron;N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)-2-(2-aminothiazol-4-yl)acetamide;YM 178;Mirabegron(YM 178)
|
米拉贝隆；米拉贝隆杂质B;2-氨基-N-[4-[2-[[(2R)-2-羟基-2-苯基乙基]氨基]乙基]苯基]-4-噻唑乙酰胺;米拉贝隆API; |
223673-61-8 |
|
Momelotinib
|
莫洛替尼 |
1056634-68-4 |
|
Dacomitinib
|
达克替尼 |
1110813-31-4 |
|
6-CHLORO-3-(1-METHYLETHYL)-2,4-(1H,3H)-PYRIMIDINEDIONE
|
马伐凯泰中间体 |
887581-47-7 |
|
Trelagliptin succinate
|
琥珀酸曲格列汀 |
1029877-94-8 |
|
Vonoprazan;1-[5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrol-3-yl]-N-methylmethanamine;
|
沃诺拉赞；富马酸沃诺他赞;沃诺拉赞间氟异构体;凡诺帕胺;沃诺拉赞; |
881681-00-1 |
|
β-NAD
|
烟酰胺腺嘌呤二核苷酸 |
53-84-9 |
|
(2S,3S)-3-Boc-amino-1,2-epoxy-4-phenylbutane
|
(2S,3S)-1,2-环氧-3-(Boc-氨基)-4-苯基丁烷 |
98737-29-2 |
|
Asciminib
|
|
1492952-76-7 |
|
Mavacamten
|
玛伐凯泰 |
1642288-47-8 |
|
TTA
|
5-甲基苯骈三氮唑 |
29385-43-1 |
|
2,4-Dichlorobenzenediazonium tetrafluoroborate
|
2,4二氯苯基重氮四氟硼酸盐 |
21872-70-8 |
|
Tolvaptan Sodium Phosphate
|
托伐普坦磷酸钠 |
942619-79-6 |
|
N-(2-Acetamido)iminodiacetic acid
|
乙酰氨基亚胺乙酸 |
26239-55-4 |
|
Selexipag
|
赛乐西帕 |
475086-01-2 |
|
VX-770
|
依伐卡托 |
873054-44-5 |
|
Trametinib free base;Mekinist trametinib;Trametinib (GSK1120212,JTP 74057);Trametinib, >=98%;CS-30;Trametinib Impurity;100836
|
曲美替尼；曲美替尼游离碱;曲美替尼、GSK1120212;曲美替尼1;MEK抑制剂(TRAMETINIB) |
871700-17-3 |
|
LEE011, >=98%;7-CYCLOPENTYL-2-(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID DIMETHYLAMIDE;LEE-011, Ribociclib;
|
瑞博西利；LEE011 瑞柏司可里布 50MG;瑞柏司可里布;LEE011 瑞柏司可里布;7-环戊基-N,N-二甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]-7H-吡咯并[2,3-D]嘧啶-6-甲酰胺; |
1211441-98-3 |
|
Acoramidis
|
阿考米迪 |
1446711-81-4 |
|
Pirtobrutinib
|
|
2101700-15-4 |
|
PF07321332(Paxlovid);nirmatrelvir;Nirmatrelvir (PF-07321332);PF-07321332-005;
|
帕罗韦德；PAXLOVID;帕克洛维德;帕罗韦德试剂;PF-07321333; |
2628280-40-8 |
|
(3S)-3-(tert-Butoxycarbonyl)amino-1-chloro-4-phenyl-2-butanone
|
(3S)-3-(叔丁氧羰基)氨基-1-氯-4-苯基-2-丁酮 |
102123-74-0 |
|
N-Desmethyl lmatinib
|
N-去甲基伊马替尼 |
404844-02-6 |
|
PA-824
|
(S)-6,7-二氢-2-硝基-6-[[4-(三氟甲氧基)苯基]甲氧基]-5H-咪唑并[2,1-B][1,3]恶嗪 |
187235-37-6 |
|
ME-DMAE-NHS
|
吖啶酯(ME-DMAE-NHS) |
115853-74-2 |
|
NSP-SA-NHS
|
吖啶酯 |
199293-83-9 |
|
Resmetirom (MGL-3196,VIA-3196);MGL-3196; MGL 3196; MGL3196; VIA-3196; VIA3196; VIA-3196;VIA3196;VIA-3196;
|
Resmetirom；RESMETIROM(MGL-3196);MGL-3196游离态;化合物MGL3196; |
920509-32-6 |
|
Resmetirom (MGL-3196,VIA-3196);MGL-3196; MGL 3196; MGL3196; VIA-3196; VIA3196; VIA-3196;VIA3196;VIA-3196;
|
Resmetirom；RESMETIROM(MGL-3196);MGL-3196游离态;化合物MGL3196; |
920509-32-6 |
|
β-NAD+-Li
|
烟酰胺腺嘌呤二核苷酸（锂盐） |
64417-72-7 |
|
0DM021;BAY-1841788;ODM-021;0DM021;ODM 021;ODM 021;ODM-021;ODM-201
|
达洛鲁胺；达罗鲁塔米德;达洛鲁胺,达罗他胺;多拉米胺;N-((S)-1-(3-(3-氯-4-氰基苯基)-1H-吡唑-1-基)丙-2-基)-5-(1-羟乙基)-1H-吡唑-3-甲酰胺 |
1297538-32-9 |
|
2-Methoxy-4-morpholinobenzenediazonium chloride zinc chloride double salt
|
2-甲氧基-4-吗啉基重氮苯氯化锌盐 |
67801-08-5 |
|
4'-AMINOPROPIOPHENONE
|
4-胺基丙苯酮 |
70-69-9 |
|
REMIBRUTINIB
|
|
1787294-07-8 |
|
Dasatinib
|
达沙替尼 |
302962-49-8 |
|
3-Guanidinopropionic acid
|
胍基丙酸 |
353-09-3 |
|
Zongertinib
|
宗格替尼 |
2728667-27-2 |
|
Ticagrelor, >=98%;Ticagrelo;Ticargrelor;Brilinta;Possia;Ticagrelor and intermediates;Ticagrelor Standards
|
替卡格雷；替格瑞洛;替卡格雷,替格雷洛,替格瑞洛;替卡格雷及中间体;替卡格雷标准品;替格瑞洛/替卡格雷;替格瑞洛;提卡格雷 |
274693-27-5 |
|
Tafamidis
|
氯苯唑酸 |
594839-88-0 |
|
5(6)-Carboxyfluorescein
|
5(6)-羧基荧光素 |
72088-94-9 |
|
Empagliflozin(W.S);Empaglifloin;Empagliflozin API;BI-10773;BI 10773;BI10773;CS-798;EMPAGLIFLBZIN;EMpagliflozin;BI-10773
|
依帕列净；艾格列净;(1S)-1,5-脱水-1-(4-氯-3-{4-[(3S)-四氢呋喃-3-基氧基]苄基}苯基)-D-葡萄糖醇; |
864070-44-0 |
|
Brexpiprazole
|
依匹哌唑 |
913611-97-9 |
|
2,4-Dichloro-5-methoxypyrimidine
|
2,4-二氯-5-甲氧基嘧啶 |
19646-07-2 |
|
nerandomilast
|
|
1423719-30-5 |
|
3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE
|
1-(1,4-二氢-1-BETA-D-呋喃核糖基-3-吡啶基)乙酮 5'-P'-(腺苷 5'-(三氢二磷酸酯))酯二钠盐 |
102029-93-6 |
|
Alogliptin benzoate
|
苯甲酸阿格列汀 |
850649-62-6 |
|
Tri(4-morpholinyl)phosphine oxide
|
三(4-吗啉基)氧化膦 |
4441-12-7 |
|
AHU-377,149709-62-6;AHU-37;AHU377; AHU 377; SACUBITRIL
|
沙库巴曲；CZ696原研900-04;塞克比曲缬沙坦复合物;AHU-377(钠盐); |
149709-62-6 |
|
IMegliMin(hydrochloride)
|
盐酸伊美格列明 |
775351-61-6 |
|
Salcaprozate Sodium
|
8-（2-羟基苯甲酰胺基）辛酸钠 |
203787-91-1 |
|
Daprodustat
|
达普司他 |
960539-70-2 |
|
Revefenacin
|
雷芬那辛 |
864750-70-9 |
|
(2R,3S)-3-(tert-Butoxycarbonyl)amino-1,2-epoxy-4-phenylbutane
|
(1S)-1-(2R)-环氧乙基-2-苯乙基氨基甲酸叔丁酯 |
98760-08-8 |
|
|
（氧化型）辅酶Ⅱ, β-烟酰胺腺嘌呤二核苷酸磷酸一钠盐 |
1184-16-3 |
|
1-(4-Nitrophenyl)acetone;2-Propanone,1-(4-nitrophenyl)-;
|
4-硝基苯丙酮；4-硝基苯丙酮, |
5332-96-7 |
|
Risdiplam
|
利司扑兰 |
1825352-65-5 |
|
AHEI
|
氨己基乙基异鲁米诺 |
66612-32-6 |
|
3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE
|
3-乙酰吡啶腺嘌呤二核苷酸 |
86-08-8 |
|
Safinamide
|
沙芬酰胺 |
133865-89-1 |
|
Methyl Green
|
甲基绿 |
7114-03-6 |
|
Cinacalcet Hydrochloride;N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride;
|
盐酸甲状旁腺激素；RAC西那卡塞-D3(甲基-D3)安泰乐;盐酸西那卡塞(盐酸甲状旁腺激素);西那卡赛盐酸盐; |
364782-34-3 |
|
ISOPROPYLUREA
|
异丙基脲 |
691-60-1 |
|
|
维生素K2（35） |
2124-57-4 |
|
5',5''-Dinitro-3',3''-diiodo-3,4,5,6-trtrabromophenol-sulfonephthalein
|
5', 5''-二硝基-3', 3''-二碘基-3,4,5,6-四溴酚磺酞 |
145551-16-2 |
|
NSP-DMAE-NHS
|
吖啶酯NSP-DMAE-NHS |
194357-64-7 |
|
Avatrombopag
|
阿伐曲泊帕 |
570406-98-3 |
|
Abemaciclib, >=98%;Abemaciclib;abemaciclib(CDK 4/6 inhibitor);Abemaciclib (LY2835219);Bemaciclib(LY2835219, abemaciclib);CDK4/6 dual inhibitor;
|
阿贝西利；阿贝昔利布;玻玛西尼;阿贝西尼;N-(5-((4-乙基哌嗪-1-基)甲基)吡啶-2-基)-5-氟-4-(4-氟-1-异丙基-2-甲基-1H-苯并[D]咪唑-6-基)嘧啶-2-胺; |
1231929-97-7 |
|
7-Chloro-[1,2,4]triazolo[1,5-a]pyridine
|
7-氯-[1,2,4]三唑并[1,5-A]吡啶 |
1427452-48-9 |
|
Mitapivat
|
米塔皮瓦 |
1260075-17-9 |
|
Finerenone (BAY 94-8862);(4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide;BAY 94-8862;BAY948862;
|
非奈利酮；化合物FINERENONE;(4S)-4-(4-氰基-2-甲氧基苯基)-5-乙氧基-1,4-二氢-2,8-二甲基-1,6-萘啶-3-甲酰胺;FINERENONE 非萘立酮 BAY 94-8862 |
1050477-31-0 |
|
ETC-1002;Bempedoic Acid;ETC-1002 (ESP 55016);ESP 55016;ETC-1002(BEMPEDOIC ACID);CS-1544;Bempedoic Acid(ETC-1002;Bempedoate
|
贝派地酸；8-羟基-2,2,14,14-四甲基十五烷二酸;贝派度酸API;8-羟基-2,2,14,14-四甲基Chemicalbook十五烷二酸(贝派度酸);苯丙醚酸;ETC-1002游离态;贝派地酸API;ETC-1002(贝派地酸) |
738606-46-7 |
|
Trilaciclib
|
曲拉西利；G1T28 ; G1T-28 ; G1T 28 ; TRILACICLIB.;曲拉西利;骨髓保护剂;化合物 T13202L |
1374743-00-6 |
|
β-NADPH
|
烟酰胺腺嘌呤二核苷酸磷酸（还原型） |
2646-71-1 |
|
ROFLUMILAST;3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide;B 9302-107;BY 217;BYK 20869;Daxas;
|
罗氟司特；/ROFLUMILAST/3-(环丙甲氧基)-N-(3,5-二氯-4-吡啶基)-4-(二氟甲氧基)苯甲酰胺;达菲宁Chemicalbook;3-(环丙基甲氧基)-N-(3,5-二氯-4-吡啶基)-4-(二氟甲氧基)苯甲酰胺; |
162401-32-3 |
|
(R)-But-3-yn-2-ol
|
R-3-丁炔-2-醇 |
42969-65-3 |
|
Trilaciclib
|
|
|
|
TAK-788
|
莫博替尼 |
1847461-43-1 |
|
ensifentrine
|
恩塞芬汀 |
1884461-72-6 |
|
Bilastine
|
比拉斯汀 |
202189-78-4 |
|
1,2,3,4-tetrahydro-benzo[h]quinolin-3-ol hydrochloride
|
1,2,3,4-四氢苯并喹啉-3-酚盐酸盐 |
73579-26-7 |
|
Rilpivirine
|
利匹韦林 |
500287-72-9 |
|
ACT 064992;ACT-064992;ACT-064992 / ACT064992;Macitentan, >=99%;
|
马西替坦；艾德拉尼中间体1;马西;马昔替坦;马西替坦 API;麦西腾坦 |
441798-33-0 |
|
Aripiprazole
|
阿立哌唑 |
129722-12-9 |
|
Niraparib
|
尼拉帕尼 |
1038915-60-4 |
|
Opicapone
|
奥匹卡朋 |
923287-50-7 |
|
vericiguat
|
维利西呱 |
1350653-20-1 |
|
Ethyl Isocyanatoacetate
|
异氰酰乙酸乙酯 |
2949-22-6 |
|
ABEI
|
N-(4-氨丁基)-N-乙基异鲁米诺 |
66612-29-1 |
|
Exatecan;DX 8951;CS-147;Exatecan Impurity;
|
依喜替康；依喜替康杂质;伊立替康杂质36;伊喜替康 |
171335-80-1 |
|
DAPAGLIFLOZIN;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol;Dapagliflozin propanediol;BMS-512148-05;Dapagliflozin S1548 Selleck;DAPAGLIFLOZIN BASE;Daglican;Dapagliflozi
|
达格列净；达格列嗪 50G;达格列净 (游离碱);达格列净 / (1S)-1,5-脱水-1-C-[4-氯-3-[(4-乙氧基苯基)甲基]苯基]-D-葡萄糖醇;达格列净(无水);达帕格列佛嗪杂质 |
461432-26-8 |
|
ABT 492 MegluMine;ABT492 MegluMine;ABT-492 MegluMine;Delafloxacin (MegluMine)
|
德拉沙星葡甲胺盐；德拉沙星N-甲基葡萄糖胺盐;德拉沙星葡甲胺盐;地拉沙星葡甲胺;德拉沙星葡甲胺; |
352458-37-8 |
|
APS-5
|
9-(4'-氯苯硫代磷酰氧亚甲基)-10-甲基-9,10-二氢化吖啶二钠盐 |
193884-53-6 |
|
Lifitegrast-d4;Lifitegrast Impurity;lifitegrast;Lifitegrast, SAR 1118
|
立他司特；利菲司特;立他斯特杂质; |
1025967-78-5 |
|
NADP
|
β-烟酰胺腺嘌呤二核苷酸磷酸，辅酶Ⅱ |
53-59-8 |
|
3-(N-tosyl-L-alanyloxy)-indole
|
3-（N-对甲苯磺酰基-L-丙氨酰氧基）-吲哚 |
75062-54-3 |
|
Zanzalintinib
|
|
2367004-54-2 |
